4:32 pm Acceleron and Celgene (CELG) announce interim clinical data for sotatercept at 2014 National Kidney Foundation Spring Clinical Meeting; Sotatercept produces dose dependent increases in hemoglobin

more

View todays social media effects on XLRN

View the latest stocks trending across Twitter. Click to view dashboard

See who Acceleron is hiring next, click here to view